Back
Vaxcyte Stock Predictions
Sponsored
PCVX
Sponsored
Unlock the Secret to Earning Monthly Income!
Limited spots act swiftly
Buy
77
PCVX
Vaxcyte
Last Price:
65.97
Seasonality Move:
7.04%
7 Day Trial
ALL ACCESS PASS
$
7
The little-known AI stock you need to read about now...
Get the name - FREE.Vaxcyte Stock Forecast
- Over the next 52 weeks, Vaxcyte has on average historically risen by 49.9% based on the past 3 years of stock performance.
- Vaxcyte has risen higher in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is Vaxcyte Stock Undervalued?
The current Vaxcyte [PCVX] share price is $65.96. The Score for PCVX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal. - PCVX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Vaxcyte Stock Go Up Next Year?
- Over the next 52 weeks, Vaxcyte has on average historically risen by 49.9% based on the past 3 years of stock performance.
Vaxcyte Stock Rating
Buy
77
Vaxcyte (PCVX)
is a Buy
Is Vaxcyte overpriced?
- Vaxcyte has risen higher in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Vaxcyte Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vaxcyte.com
52-Week Data
52-Week High:
82.04
52-Week Low:
44.20
Prediction Charts
Market Cap:
7.15B
Price in USD:
65.96
Volume:
618.8K
Beta:
0.96
Technical Analysis
SMA50:
67.00
SMA100:
66.42
SMA200:
58.00
52-Wk Change:
33.28%
Stock Predictions
-
Is Vaxcyte stock public?
Yes, Vaxcyte is a publicly traded company. -
What is the Vaxcyte stock quote today?
The Vaxcyte stock price is 65.96 USD today. -
How to buy Vaxcyte stock online?
You can buy Vaxcyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-16 | 62.17 | 62.29 | 62.86 | 61.84 |
Apr-17 | 62.65 | 62.43 | 63.44 | 61.78 |
Apr-18 | 62.15 | 60.62 | 62.21 | 60.58 |
Apr-19 | 60.46 | 60.88 | 61.92 | 59.39 |
Apr-22 | 61.47 | 61.60 | 63.22 | 60.91 |
Apr-23 | 61.79 | 60.88 | 62.56 | 60.83 |
Apr-24 | 61.05 | 60.30 | 61.98 | 59.97 |
Apr-25 | 59.59 | 60.06 | 60.09 | 58.10 |
Apr-26 | 60.32 | 60.72 | 60.95 | 59.41 |
Apr-29 | 61.07 | 61.03 | 62.29 | 60.72 |
Apr-30 | 60.61 | 60.54 | 61.20 | 58.84 |
May-1 | 60.76 | 63.71 | 64.24 | 60.21 |
May-2 | 63.83 | 64.55 | 65.00 | 63.11 |
May-3 | 66.48 | 65.96 | 67.08 | 65.46 |
Vaxcyte Earnings
Vaxcyte Earnings Report: Per Share Vaxcyte Earnings Q1 Q2 Q3 and Q4 last year and next year.
Vaxcyte Forecast Revenue Growth
Vaxcyte Stock Analysis: Historical quarterly revenues per share for Vaxcyte and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.85 per share, and a decrease next year of $0.05 per share.
* Vaxcyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.